Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2 (eBAM_CoV)
SARS-CoV-2 Infection, COVID-19, Coronavirus
About this trial
This is an interventional diagnostic trial for SARS-CoV-2 Infection focused on measuring Diagnostic Test Kits
Eligibility Criteria
Inclusion Criteria: Adult male or female patients over 18 years of age (≥) Suspected of being infected with COVID-19 (symptomatic or contact case) and consulting for RT-PCR screening. Exclusion Criteria: Inability to understand the procedures to use the device Patient participating in an another interventional study Patient in exclusion period determined by another study Patient under court protection or guardianship Patient/trusted person/legal representative/family member for whom it is impossible to give informed information. Pregnant, parturient or breast-feeding patient
Sites / Locations
- Laboratoire Alphabio, Hôpital Européen Marseille
- CHU de NIMES
Arms of the Study
Arm 1
Experimental
Patients likely to be affected by COVID-19
The study population consists of adult people who are likely to be affected by COVID-19 (symptomatic or close contacts) consulting for RT-PCR screening.